| Literature DB >> 23902802 |
Michelle M Simon, Simon Greenaway, Jacqueline K White, Helmut Fuchs, Valérie Gailus-Durner, Sara Wells, Tania Sorg, Kim Wong, Elodie Bedu, Elizabeth J Cartwright, Romain Dacquin, Sophia Djebali, Jeanne Estabel, Jochen Graw, Neil J Ingham, Ian J Jackson, Andreas Lengeling, Silvia Mandillo, Jacqueline Marvel, Hamid Meziane, Frédéric Preitner, Oliver Puk, Michel Roux, David J Adams, Sarah Atkins, Abdel Ayadi, Lore Becker, Andrew Blake, Debra Brooker, Heather Cater, Marie-France Champy, Roy Combe, Petr Danecek, Armida di Fenza, Hilary Gates, Anna-Karin Gerdin, Elisabetta Golini, John M Hancock, Wolfgang Hans, Sabine M Hölter, Tertius Hough, Pierre Jurdic, Thomas M Keane, Hugh Morgan, Werner Müller, Frauke Neff, George Nicholson, Bastian Pasche, Laura-Anne Roberson, Jan Rozman, Mark Sanderson, Luis Santos, Mohammed Selloum, Carl Shannon, Anne Southwell, Glauco P Tocchini-Valentini, Valerie E Vancollie, Henrik Westerberg, Wolfgang Wurst, Min Zi, Binnaz Yalcin, Ramiro Ramirez-Solis, Karen P Steel, Ann-Marie Mallon, Martin Hrabě de Angelis, Yann Herault, Steve D M Brown.
Abstract
BACKGROUND: The mouse inbred line C57BL/6J is widely used in mouse genetics and its genome has been incorporated into many genetic reference populations. More recently large initiatives such as the International Knockout Mouse Consortium (IKMC) are using the C57BL/6N mouse strain to generate null alleles for all mouse genes. Hence both strains are now widely used in mouse genetics studies. Here we perform a comprehensive genomic and phenotypic analysis of the two strains to identify differences that may influence their underlying genetic mechanisms.Entities:
Mesh:
Year: 2013 PMID: 23902802 PMCID: PMC4053787 DOI: 10.1186/gb-2013-14-7-r82
Source DB: PubMed Journal: Genome Biol ISSN: 1474-7596 Impact factor: 13.583
Coding single-nucleotide polymorphisms and small indels identified in the comparison between C57BL/6N and C57BL/6J
| Chr | Position | B6J | B6N | Strain | Gene name | B6J | B6N |
|---|---|---|---|---|---|---|---|
| Nonsense polymorphism | |||||||
| 13 | 65023280 | C | T | B6N | Arginine | *(stop) | |
| Missense polymorphisms | |||||||
| 1 | 59904011 | G | A | B6N | Arginine | Glutamine | |
| 3 | 95538799 | T | C | B6J | Isoleucine | Valine | |
| 3 | 96658480 | A | G | B6J | Asparagine | Aspartic acid | |
| 4 | 21800831 | C | G | B6J | Arginine | Glycine | |
| 4 | 137777588 | C | T | B6N | Leucine | Phenylalanine | |
| 4 | 140354038 | A | G | B6N | Leucine | Proline | |
| 4 | 148318468 | T | C | B6J | Leucine | Proline | |
| 5 | 90204376 | C | T | B6N | Valine | Isoleucine | |
| 5 | 97187161 | T | C | B6J | Leucine | Proline | |
| 5 | 113191741 | C | T | B6N | Arginine | Histidine | |
| 6 | 39350455 | T | A | B6J | Asparagine | Tyrosine | |
| 7 | 3222538 | T | C | B6J | Lysine | Arginine | |
| 7 | 63386662 | G | A | B6J | Glycine | Aspartic acid | |
| 7 | 86256240 | A | C | B6J | Histidine | Proline | |
| 7 | 110121823 | C | T | B6N | Valine | Isoleucine | |
| 7 | 127278693 | G | A | B6N+Spretus | Alanine | Valine | |
| 7 | 129311164 | C | T | B6N | Arginine | Tryptophan | |
| 9 | 24935069 | C | G | B6N | Valine | Leucine | |
| 10 | 66700922 | T | C | B6J | Leucine | Proline | |
| 10 | 78632222 | A | G | B6N | Asparagine | Serine | |
| 10 | 87554578 | T | C | B6N | Isoleucine | Threonine | |
| 11 | 46036117 | G | A | B6N | Serine | Phenylalanine | |
| 11 | 90341985 | C | T | B6N | Threonine | ||
| 13 | 21560172 | A | G | B6J | Glycine | Arginine | |
| 13 | 73465884 | A | G | B6J | Valine | Alanine | |
| 13 | 93833534 | C | G | B6J | Alanine | Proline | |
| 14 | 70986011 | G | T | B6N | Serine | Arginine | |
| 15 | 11266138 | G | T | B6N | Cysteine | Phenylalanine | |
| 15 | 77468437 | A | C | B6J | Isoleucine | Arginine | |
| 16 | 35291630 | G | A | B6N | Valine | Methionine | |
| 17 | 47537359 | T | C | B6J | Isoleucine | Valine | |
| X | 131227581 | C | A | B6N | Alanine | Aspartic acid | |
| Splice site polymorphism | |||||||
| 5 | 54280548 | A | G | B6J | - | - | |
| Frameshift 1 bp deletions | |||||||
| 1 | 141133664 | G | - | B6N | - | - | |
| 9 | 65127938 | G | - | B6J | - | - | |
Abbreviations: Chr, chromosome.
Structural variants (SVs) between C57BL/6N and C57BL/6J
| Chr | SV starta | SV stopa | Ancestral event | Strain | Gene | Overlap |
|---|---|---|---|---|---|---|
| 1 | 149518394 | 149524878 | LINE Ins | B6J | - | - |
| 2 | 7325700 | 7330977 | IAP Ins | B6J | - | - |
| 2 | 70619835 | 70620080 | SINE Ins | B6J | Intron | |
| 3 | 77975065 | 77977953 | Del | B6N | - | - |
| 3 | 5049018 | 5055845 | LINE Ins | B6J | - | - |
| 3 | 60336036 | 60336037 | Del (large) | B6J | Intron | |
| 3 | 41885819 | 41887255 | LINE Ins | B6J | - | - |
| 3 | 18484710 | 18484889 | Del | B6N | - | - |
| 4 | 101954274 | 101954395 | Del | B6N | Intron | |
| 4 | 116051393 | 116051799 | MaLR Ins | B6J | Intron | |
| 5 | 46376307 | 46377852 | LINE Ins | B6J | - | - |
| 5 | 90356490 | 90356491 | Del (~300 bp) | B6J | - | - |
| 5 | 146248861 | 146261885 | Ins | B6J+others | - | - |
| 6 | 18112291 | 18119019 | LINE Ins | B6J | - | - |
| 6 | 62964974 | 62972907 | LINE Ins | B6J | - | - |
| 6 | 86478779 | 86479400 | Ins | B6J | - | - |
| 6 | 103669536 | 103676487 | LINE Ins | B6J | Intron | |
| 6 | 104207081 | 104214434 | LINE Ins | B6J | - | - |
| 7 | 92095990 | 92096149 | Del | B6N | Exon | |
| 7 | 27636128 | 27748456 | Ins | B6J | Entire | |
| 7 | 100892501 | 100899058 | LINE Ins | B6J | - | - |
| 7 | 139306094 | 139307981 | MaLR Ins | B6J | Intron | |
| 8 | 16716381 | 16716382 | Del (large) | B6J | Intron | |
| 9 | 25674550 | 25674770 | SINE Ins | B6J | - | - |
| 9 | 58544415 | 58546304 | MaLR Ins | B6J | Intron | |
| 10 | 3039196 | 3039197 | Del (large) | B6J | - | - |
| 10 | 29339441 | 29345955 | LINE Ins | B6J | - | - |
| 10 | 32536420 | 32543464 | LINE Ins | B6J | Intron | |
| 10 | 49543303 | 49550645 | LINE Ins | B6J | - | - |
| 11 | 104906390 | 104906621 | Del | B6N | - | - |
| 11 | 119560391 | 119566827 | MTA Ins | B6J | Intron | |
| 12 | 42023964 | 42032747 | Del | B6N | Intron | |
| 13 | 71224557 | 71231011 | MTA Ins | B6J | - | - |
| 13 | 120164268 | 120164269 | Del (large) | B6J | Exon | |
| 14 | 112825585 | 112832341 | LINE Ins | B6J | - | - |
| 15 | 49554596 | 49554597 | Ins (large) | B6N | - | - |
| 15 | 31106173 | 31106382 | VNTR | - | - | - |
| 16 | 6115804 | 6138105 | Del | B6N | - | - |
| 17 | 60286367 | 60286368 | Ins (~2000 bp) | B6N | - | - |
| 18 | 4809271 | 4809272 | Del (~1200 bp) | B6J | - | - |
| 19 | 12863187 | 12863188 | Del (~1800 bp) | B6J | Intron | |
| X | 15697909 | 15697910 | Del (~400 bp) | B6J | - | - |
| X | 95155499 | 95163160 | LINE Ins | B6J | - | - |
Abbreviations: Del, deletion; IAP, intracisternal A particle; Ins, insertion; LINE, long interspersed nuclear element; MaLR, mammalian apparent long terminal repeat retrotransposon; MTA, member of transcript retrotransposon; SINE, short interspersed nuclear element; VNTR, variable number tandem repeat.
Start and stop coordinates are given for MGSCv37 of the mouse reference genome.
Figure 1Heat maps illustrating significant differences in phenotype parameters between C57BL/6N and C57BL/6J male and female mice. Parameters were assessed from each of the four centers: Helmholtz Zentrum Munchen (HMGU), Institut Clinique Souris (ICS), MRC Harwell, and the Wellcome Trust Sanger Institute (WTSI). Parameter designations and parameter descriptions are from EMPReSSslim [37]. Significance levels and the direction of the effect (red and green) are defined in the key. Significant differences for categorical data are illustrated in blue. (A, B) Phenotype parameters showing a significant difference between N and J in (A) three or more centers, and (B) in two centers but no evidence of trends in the other centers.
Figure 2Heat maps illustrating significant differences in phenotype parameters between C57BL/6N and C57BL/6J male and female mice. Parameters were assessed from each of the four centers (Helmholtz Zentrum Munchen (HMGU), Institut Clinique Souris (ICS), MRC Harwell, and the Wellcome Trust Sanger Institute (WTSI)). Phenotype parameters that showed significant differences in two or more centers, but the opposite trend in another center. Parameter designations and parameter descriptions are from EMPReSSslim. Significance levels and the direction of the effect (red and green) are defined in the key.
Figure 3Morphological and functional differences between C57BL/6N and C57BL/6J mice eyes. (A) Whereas white flecks were absent from C57BL/6J fundus, they were frequently detected in the ventral retina from C57BL/6N mice, with various degrees of severity, as illustrated here by three C57BL/6N fundus images. Depending on the investigating center, C57BL/6N mice with at least one eye affected represented 69.2% (n = 70 males + 34 females; ICS), 44.6% (n = 145 males + 158 females; GMC), or 23.0% (n = 184 males + 194 females; WTSI) of the population, whereas no flecking was detected in C57BL/6J mice (ICS: 29 males; GMC: 75 males + 75 females; WTSI: 34 males + 28 females). (B) Both vein and artery numbers differed from mouse to mouse in both strains, usually being between (left) three and (right) seven, with (middle) a mean of around five, as can be seen in three fundus images from C57BL/6J mice. (C) Quantification of veins and arteries in male C57BL/6N and C57BL/6J mice (n = 140 and n = 70 eyes, respectively). The mean number of veins per eye was 4.8 ± 0.1 for C57BL/6N (n = 122 eyes) versus 5.3 ± 0.1 for C57BL/6J mice (n = 138 eyes). Both differences were significant (P < 0.001, Mann-Whitney rank sum test).
Figure 4Micro-computed tomography (μCT) analysis of distal femur showed similar trabecular bone parameters in 14-week-old C57BL/6J and C57BL/6N mice. (A) Males and (B) females. (C) Cortical bone parameters from midshaft femur of 14-week-old male mice were also unchanged between the two strains. (D) Measurement of serum osteocalcin and urinary deoxypyridinoline (bone formation and bone resorption markers, respectively), indicates that bone turnover was identical between 14-week-old C57BL/6J and C57BL/6N. Abbreviations: BV/TV, bone volume/tissue volume; TbN, trabecular number; TbSp, Trabecular spacing; Conn-Dens, Connectivity density; SMI, structural model index (0 for parallel plates, 3 for cylindrical rods); DA, degree of anisotropy; CtPo, cortical porosity; CtTh, cortical thickness; DPD, deoxypyridinoline; creat, creatinin.
Figure 5Light/dark test. Bars represent (A) the latency to enter, (B) the percentage of time spent in the dark compartment (C) and the number of light/dark transitions by C57BL/6J (n = 10) and C57BL/6N (n = 9) male mice, aged 8 to 10 weeks. Data are mean ± SEM, *P < 0.05 (t-test). (D) Rotarod motor learning performance over 4 days. Symbols and lines represent daily latencies (mean ± SEM) to fall from rotating rod at acceleration from 4 to 40 rpm in 300 seconds by C57BL/6J (n = 10) and C57BL/6N (n = 10) male mice, aged 9 to 11 weeks. *P < 0.05, **P < 0.005, ***P < 0.0001 J versus. N (t-test); °P < 0.05, °°P < 0.005, °°°P < 0.0001 versus day 1, Fisher's (least squares difference).
Figure 6Morris water maze. (A) Learning curves for familiarization and training phases Symbols and lines represent daily latencies (mean ± SEM) to reach the platform by C57BL/6J (n = 10) and C57BL/6N (n = 10) male mice, aged 16 to 20 weeks. **P < 0.005, ***P < 0.0005 J versus N (t-test); °°P < 0.005, °°°P < 0.0001 versus day 1 (Fisher's least squares difference). (B) Probe test. Bars represent % time spent in each quadrant on day 5 during probe test. Dotted line is set at chance level (25%). *P < 0.05, **P < 0.005, ***P < 0.0005 versus correct quadrant (t-test)_. (C) Representative tracks of two C57BL/6J and C57BL/6N mice paths during probe test. Dotted circle indicates former platform location.
Figure 7Comparison of . (A) Kaplan-Meier survival curves of females and males of the C57BL/6J and C57BL/6N strains after intravenous (IV)v. infection with 2 × 104 colony-forming units (cfu) of Listeria monocytogenes strain EGD. (B) Bacterial load in liver and spleen of C57BL/6J and C57BL/6N mice after IV infection with 2 × 104 cfu L. monocytogenes EGD. Organ loads were ascertained at four time points to analyze kinetics of bacterial growth. (C) Comparison of plasma levels of interleukin (IL)-6, interferon-inducible protein (IP)-10, and chemokine ligand (CCL)2 between the C57BL/6J and C57BL/6N mice shown in (B). Concentrations of pro-inflammatory cytokines and chemokines were determined in peripheral blood samples using the Cytokine Mouse 20-Plex Panel (Invitrogen Inc., Foster City, CA, USA) and a LiquiChip 100 system (Qiagen, Hilden, Germany). Significant differences are indicated as follows: *P < 0.05, **P < 0.01 Mann-Whitney, U-test. Black bars and symbols, C57BL/6J inbred strain. White bars and symbols, C57BL/6N inbred strain.
Figure 8Measurement of splenic natural killer (NK) cells and hapten-specific hypersensitivity. (A) Splenic NK cell activity of C57BL/6J (B6J) versus C57BL/6N (B6NTac) mice: (upper panel) male and (lower panel) female. Splenic NK cells from C57BL/6J or C57BL/6N mice were stimulated under the indicated conditions (six mice per group). Mean ± SD of interferon (IFN)γ-positive cells among a population of CD3- NK1.1+ NK cells was measured by flow cytometry. (B) Hapten-specific hypersensitivity. Male or female C57BL/6J or C57BL/6N mice were sensitized by the application of 25 μl of 0.5% dinitrofluorobenzene (DNFB) solution on the ventral skin. They were then challenged by the application of 5 μl of 0.15% DNFB solution on the left ear 5 days later (DNFB group). The right ears were painted with vehicle (-) and used as controls. Ear thickness was measured 48 hours after challenge. Results are representative of three independent experiments with six mice per group. *P < 0.05; **P < 0.005 (Mann-Whitney U-test).
Comparison of predicted effects of SNPs and SVs that might contribute to the phenotypic differences between C57BL/6N and C57BL/6J.a
| Protein coding gene | C57BL/6J amino acid | C57BL/6N amino acid | SNP is private to: | PROVEAN prediction (score)b | MP terms | B6J versus B6N2 | B6N versus B6Jc |
|---|---|---|---|---|---|---|---|
| Valine (V) | Methionine (M) | B6N | Tolerated | Impaired coordination_MP:0001405 | NR | P | |
| Hypoactivity_MP:0001402 | NR | P | |||||
| Isoleucine (I) | Threonine (T) | B6N | Tolerated (0.493) | Decreased circulating glucose level_MP:0005560 | NR | A | |
| Abnormal glucose tolerance_MP:0005291 | NR | A | |||||
| Increased oxygen consumption_MP:0005289 | NR | P | |||||
| Asparagine (N) | Aspartic Acid (D) | B6J | Tolerated (0.95) | Increased circulating cholesterol level_MP:0001556 | A | NR | |
| Lysine | Arginine | B6J | Tolerated (0.781) | Abnormal type IV hypersensitivity reaction_MP:0002534 | P | NR | |
| - | - | B6N | - | Photosensitivity_MP:0001999 | NR | P | |
| Abnormal ocular fundus morphology_MP:0002864 | NR | P | |||||
| Retinal degeneration_MP:0001326 | NR | P | |||||
| Abnormal retinal morphology_MP:0001325 | NR | P | |||||
| Abnormal retinal photoreceptor layer_MP:0003728 | NR | P | |||||
| - | - | B6J | - | Abnormal learning/memory_ MP:0001449 | A | NR | |
| Abnormal spatial working memory_MP:0008428 | A | NR | |||||
| - | - | B6J | - | Increased lean body mass_MP:0003960 | P | NR | |
| Increased oxygen consumption_MP:0005289 | A | NR | |||||
| Hypoactivity_MP:0001402 | A | NR | |||||
| Decreased circulating glucose level_MP:0005560 | P | NR | |||||
| Improved glucose tolerance_MP:0005292 | A | NR | |||||
| - | - | B6J | - | Impaired glucose tolerance_MP:0005293 | P | NR |
Abbreviations: A, phenotype absent; MP, Mammalian Phenotype; NP, Single-nucleotide polymorphism; NR, not relevant; P, phenotype present; PROVEAN, Protein Variation Effect Analyzer; SOP, Standard operating procedure; SV, structural variant.
aWe have identified variant genes that show homozygote knockout phenotypes with associated MP terms that were assessed in the phenotyping pipeline, and compared these phenotypes to those seen between N and J.
bThreshold for intolerance is -2.3.
cThese columns indicate the direction of the phenotype effect that might be seen given the assignment of a SNP or SV as private to B6J or B6N. Only one direction will be relevant and comparable with the effects of the knockout mutation.